Skip to main content

Pulik Richard's Form 4 filing

Roivant Sciences Ltd. (ROIV) · filed Dec 29, 2025

Accession no.
0001140361-25-046787
Filed
Dec 29, 2025
Trade date
Dec 23, 2025
Filing delay
6 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $9.12M. It was filed 6 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pulik RichardCIK 0001885841Officer (CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 23, 2025Common SharesMOption exerciseAcquired+260,000$3.85+$1,001,000646,144Direct
Dec 23, 2025Common SharesSSaleDisposed−260,000$22.45−$5,837,000386,144Direct
Dec 23, 2025Common SharesSSaleDisposed−146,731$22.39−$3,285,307.09239,413Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 23, 2025Common StockMOption exerciseDisposed−260,000$0.00$0740,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)